For laboratory research use only — not for human or veterinary consumption.
The Peptide Index
Dosing guide

AOD-9604 Dosage Chart & Schedule

A modified fragment of the C-terminus of human growth hormone (residues 176-191) studied for fat metabolism without the full growth-promoting effects of intact GH.

Route
Subcutaneous
Frequency
Daily
Half-life
Short in circulation
Storage
Refrigerate reconstituted; keep lyophilized cool + dark
The short answer

Research-community references converge on a single reference dose of about 300 mcg per day subcutaneously. Obesity trials of the compound did not reach approval for that indication.

Figures describe how AOD-9604 is reported in the research literature and research-community references — not a recommendation for human use. For laboratory research only.

Dosage protocols

Commonly referenced research tiers. Start conservative; every compound and study context differs.

Most commonStandard
300 mcg
per injection
Frequency
Once daily
Weekly total
2.1 mg/week
Cycle
Ongoing or cycled

The commonly referenced daily amount, often described as a morning, fasted injection; there is no established titration ladder.

A growth-hormone fragment

  • A modified fragment of the growth-hormone C-terminus (residues 176-191) studied for lipolysis without the growth-promoting effects of intact GH.
  • Clinical obesity trials did not achieve approval for that indication, so dosing reflects research references rather than a labeled regimen.

Ready to run this protocol?

Dosing is only as good as the vial. Research-grade peptides are third-party tested with published COAs from our top-rated source — reconstitute with confidence and skip the guesswork on identity and purity.

Weekly schedule

A typical week on the standard protocol (Once daily).

Mon
Tue
Wed
Thu
Fri
Sat
Sun

Dosing day Off

AOD-9604 reconstitution

5 mg vial + 2 mL bacteriostatic water = 2500 mcg/mL.

Concentration
2,500 mcg/mL
Per syringe unit
25 mcg
Draw for 300 mcg
12 units
Doses per vial
~16
Open this mix in the calculator →

From vial to injection in 6 steps

1

Wipe both vial tops

Swab the peptide vial and the bacteriostatic-water vial with fresh alcohol and let them dry.

2

Draw the water

Pull the planned amount of bacteriostatic water (2 mL) into the syringe.

3

Add it slowly

Run the water down the inside wall of the vial — don't blast the powder. Swirl gently; never shake.

4

Let it dissolve

Wait until the solution is fully clear, then refrigerate the vial.

5

Draw your dose

Pull the calculated units on a U-100 insulin syringe (~12 units for 300 mcg).

6

Store between uses

Keep the reconstituted vial refrigerated and use within its stable window.

Handling & storage

  • A 5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL, so 300 mcg draws to about 12 units on a U-100 syringe.
  • Commonly referenced as a single morning dose; refrigerate after reconstitution.
  • Keep the lyophilized powder cool and dark before mixing.

AOD-9604 dosing FAQ

What is the reference dose?

Research-community sources commonly cite about 300 mcg per day subcutaneously, with no established titration schedule.

When is it usually taken?

It is frequently referenced as a single morning, fasted injection, though timing is a research-community convention rather than a validated protocol.

What draws up on a syringe?

From a 5 mg vial in 2 mL (2.5 mg/mL): 300 mcg is about 0.12 mL, or roughly 12 units on a U-100 insulin syringe.

Sources

Categories: GLP-1 & Metabolic · Status: Research use only. This page is educational and for laboratory research use only; it is not medical advice.